Evidence map›Paper›PMID 34414474›Full record

ReviewCellular and molecular life sciences : CMLS2021

Transcriptional enhancers and their communication with gene promoters.

Helen Ray-Jones, Mikhail Spivakov

Open access · hybridAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
6.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. The Binding Landscape of an Essential Nuclear Hormone Receptor inbioRxiv : the preprint server for biology · 2025
    Article
  14. Review
  15. Interaction Between Enhancers and Promoters in Chicken Genome.International journal of molecular sciences · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Update on the genetics of allergic diseases.The Journal of allergy and clinical immunology · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Helen Ray-JonesMRC London Institute of Medical Sciences, London, W12 0NN, UK.ORCID http://orcid.org/0000-0002-8884-6865
Mikhail SpivakovMRC London Institute of Medical Sciences, London, W12 0NN, UK. mikhail.spivakov@lms.mrc.ac.uk.ORCID http://orcid.org/0000-0002-0383-3943
MRC London Institute of Medical Sciences · GBNIHR Imperial Biomedical Research Centre · GB

Funding

Medical Research Council MC_UP_1605/3
6 · The paper itself

Abstract

Transcriptional enhancers play a key role in the initiation and maintenance of gene expression programmes, particularly in metazoa. How these elements control their target genes in the right place and time is one of the most pertinent questions in functional genomics, with wide implications for most areas of biology. Here, we synthesise classic and recent evidence on the regulatory logic of enhancers, including the principles of enhancer organisation, factors that facilitate and delimit enhancer-promoter communication, and the joint effects of multiple enhancers. We show how modern approaches building on classic insights have begun to unravel the complexity of enhancer-promoter relationships, paving the way towards a quantitative understanding of gene control.

Indexed as

AnimalsCommunicationEnhancer Elements, GeneticGene Expression RegulationHumansPromoter Regions, GeneticTranscription, GeneticChromosomal conformationEnhancer–promoter interactionsGene regulationTranscriptional enhancers

Identifiers

PMID34414474
PMCPMC8558291
OpenAlexW3195367710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.